Serraj Khalid, Mecili Mustapha, Housni Ibrahim, Andrès Emmanuel
Hôpitaux universitaires de Strasbourg, clinique médicale B, service de médecine interne, diabète et maladies métaboliques, 67091 Strasbourg cedex, France.
Presse Med. 2011 Dec;40(12 Pt 1):1120-7. doi: 10.1016/j.lpm.2011.08.010. Epub 2011 Oct 22.
Hypervitaminemia B12 or high serum level of cobalamin B12 is a frequent and clinical underestimated abnormality. Clinically, it can be sometimes paradoxically accompanied by signs of deficiency reflecting a functional deficit in relation to qualitative abnormalities related to defects in tissue uptake and action of vitamin B12. Etiological profile of hypervitaminemias B12 has mostly serious disease entities and for which early diagnosis is crucial to the plan rather than prognostic. These entities are represented mainly by solid malignancies, hematological malignancies and liver diseases. This reflects the potential significance that may have the dosage of vitamin B12 as an early marker of diagnosis of these diseases. Codified approach is needed to determine the potential indications of the search for a hypervitaminemia B12 and practice what to do to pass before the discovery of a high serum level of cobalamin.
维生素B12血过多症或血清钴胺素B12水平升高是一种常见但临床诊断中常被低估的异常情况。临床上,它有时可能会自相矛盾地伴有缺乏症状,这反映出与维生素B12组织摄取和作用缺陷相关的定性异常所导致的功能缺陷。维生素B12血过多症的病因大多与严重疾病相关,早期诊断对于治疗方案而非预后至关重要。这些疾病主要包括实体恶性肿瘤、血液系统恶性肿瘤和肝脏疾病。这反映出维生素B12检测作为这些疾病早期诊断标志物的潜在重要性。需要一种规范化的方法来确定筛查维生素B12血过多症的潜在指征,以及在发现血清钴胺素水平升高之前应采取的措施。